Metformin in pancreatic cancer treatment: from clinical trials through basic research to biomarker quantification
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin in pancreatic cancer treatment: from clinical trials through basic research to biomarker quantification
Authors
Keywords
Metformin, Pancreatic cancer, Cancer biology, Clinical trials, Biomarkers
Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume 142, Issue 10, Pages 2159-2171
Publisher
Springer Nature
Online
2016-05-10
DOI
10.1007/s00432-016-2178-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- From obesity to diabetes and cancer: epidemiological links and role of therapies
- (2016) Custodia García-Jiménez et al. BRITISH JOURNAL OF CANCER
- Metformin and pancreatic cancer: Is there a role?
- (2016) Andre De Souza et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Mechanism of Metformin: A Tale of Two Sites
- (2016) Ruisheng Song DIABETES CARE
- Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial
- (2016) Takuma Higurashi et al. LANCET ONCOLOGY
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Metformin Treatment Does Not Inhibit Growth of Pancreatic Cancer Patient-Derived Xenografts
- (2016) Matthew B. Lipner et al. PLoS One
- The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development
- (2016) Jun Gong et al. Targeted Oncology
- The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy
- (2016) Younak Choi et al. Cancer Research and Treatment
- Effect of Metformin Use on Survival in Resectable Pancreatic Cancer: A Single-Institution Experience and Review of the Literature
- (2016) Chenwi M. Ambe et al. PLoS One
- Repurposing metformin: an old drug with new tricks in its binding pockets
- (2015) R. Pryor et al. BIOCHEMICAL JOURNAL
- IGF-IR: a new prognostic biomarker for human glioblastoma
- (2015) C Maris et al. BRITISH JOURNAL OF CANCER
- Combining clinicopathological predictors and molecular biomarkers in the oncogenic K-RAS/Ki67/HIF-1α pathway to predict survival in resectable pancreatic cancer
- (2015) R Qin et al. BRITISH JOURNAL OF CANCER
- New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications and risk of pancreatic cancer
- (2015) Yunxia Lu et al. BRITISH JOURNAL OF CANCER
- New avenues for improving pancreatic ductal adenocarcinoma (PDAC) treatment: Selective stroma depletion combined with nano drug delivery
- (2015) Archana Bhaw-Luximon et al. CANCER LETTERS
- Abstract LB-183: Metformin use does not increase survival of pancreatic cancer patients: A cautionary lesson
- (2015) Roongruedee Chaiteerakij et al. CANCER RESEARCH
- MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells
- (2015) Patricia Sancho et al. Cell Metabolism
- (Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial
- (2015) M. Reni et al. CLINICAL CANCER RESEARCH
- Shutting Down the Furnace: Preferential Killing of Cancer Cells with Mitochondrial-Targeting Molecules
- (2015) Cláudia Deus et al. CURRENT MEDICINAL CHEMISTRY
- Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
- (2015) Sil Kordes et al. LANCET ONCOLOGY
- Metformin and prostate cancer stem cells: a novel therapeutic target
- (2015) M J Mayer et al. PROSTATE CANCER AND PROSTATIC DISEASES
- New mechanisms of metformin action: Focusing on mitochondria and the gut
- (2015) Kyu Yeon Hur et al. Journal of Diabetes Investigation
- Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma
- (2015) Xinke Zhou et al. Oncotarget
- Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling
- (2015) Xinqun Chai et al. Scientific Reports
- Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis
- (2015) Takla Griss et al. PLOS BIOLOGY
- Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker Assessment
- (2015) Kunal Amratlal Lodhia et al. Frontiers in Oncology
- Metformin Promotes Apoptosis but Suppresses Autophagy in Glucose-Deprived H4IIE Hepatocellular Carcinoma Cells
- (2015) Deok-Bae Park Diabetes & Metabolism Journal
- Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages
- (2015) Joao Incio et al. PLoS One
- Organic cation transporter-mediated drug–drug interaction potential between berberine and metformin
- (2014) Mihwa Kwon et al. ARCHIVES OF PHARMACAL RESEARCH
- Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria
- (2014) Hannah R. Bridges et al. BIOCHEMICAL JOURNAL
- Cancer, metabolism, fructose, artificial sweeteners, and going cold turkey on sugar
- (2014) Lewis C Cantley BMC BIOLOGY
- Oncogenic KRAS signalling in pancreatic cancer
- (2014) S Eser et al. BRITISH JOURNAL OF CANCER
- Prognostic significance of AMPK activation in advanced stage colorectal cancer treated with chemotherapy plus bevacizumab
- (2014) E Zulato et al. BRITISH JOURNAL OF CANCER
- Metformin impairs growth of endometrial cancer cells via cell cycle arrest and concomitant autophagy and apoptosis
- (2014) Akimasa Takahashi et al. Cancer Cell International
- mTOR is a promising therapeutical target in a subpopulation of pancreatic adenocarcinoma
- (2014) Wesley K. Utomo et al. CANCER LETTERS
- Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders
- (2014) S. Gandini et al. Cancer Prevention Research
- Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: A systematic review and meta-analysis
- (2014) Zheng Wang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Targeting mTOR dependency in pancreatic cancer
- (2014) Douglas C Morran et al. GUT
- Mechanism of Metformin-dependent Inhibition of Mammalian Target of Rapamycin (mTOR) and Ras Activity in Pancreatic Cancer
- (2014) Vijayalekshmi Nair et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
- (2014) Anila K. Madiraju et al. NATURE
- Insulin-Like Growth Factor 1 Receptor (IGF-1R) as a Target of MiR-497 and Plasma IGF-1R Levels Associated with TNM Stage of Pancreatic Cancer
- (2014) Jian-Wei Xu et al. PLoS One
- Targeting Insulin-Like Growth Factor 1 Receptor Inhibits Pancreatic Cancer Growth and Metastasis
- (2014) Ramadevi Subramani et al. PLoS One
- Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells
- (2014) Ming Ming et al. PLoS One
- Biomarker Development for the Clinical Activity of the mTOR Inhibitor Everolimus (RAD001): Processes, Limitations, and Further Proposals
- (2014) Terence O'Reilly et al. Translational Oncology
- Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling
- (2014) Altaf Mohammed et al. Translational Oncology
- Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling
- (2014) Y Feng et al. Cell Death & Disease
- A case–control study comparing the incidence of early symptoms in pancreatic and biliary tract cancer
- (2014) M G Keane et al. BMJ Open
- Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
- (2014) William W Wheaton et al. eLife
- Diabetes, pancreatic cancer, and metformin therapy
- (2014) Jun Gong et al. Frontiers in Physiology
- The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers
- (2014) Elisavet Paplomata et al. Therapeutic Advances in Medical Oncology
- LKB1 and AMPK and the cancer-metabolism link - ten years after
- (2013) D Hardie et al. BMC BIOLOGY
- IGF-1 receptor and IGF binding protein-3 might predict prognosis of patients with resectable pancreatic cancer
- (2013) Toshiki Hirakawa et al. BMC CANCER
- Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells
- (2013) Emelie Karnevi et al. BMC CANCER
- Stromal disrupting effects of nab-paclitaxel in pancreatic cancer
- (2013) R Alvarez et al. BRITISH JOURNAL OF CANCER
- Excess glucose induces hypoxia-inducible factor-1α in pancreatic cancer cells and stimulates glucose metabolism and cell migration
- (2013) Zhiwen Liu et al. CANCER BIOLOGY & THERAPY
- Glucose promotes breast cancer aggression and reduces metformin efficacy
- (2013) Reema Wahdan-Alaswad et al. CELL CYCLE
- Exploiting the bad eating habits of Ras-driven cancers
- (2013) E. White GENES & DEVELOPMENT
- The role of insulin and IGF system in pancreatic cancer
- (2013) Marija Trajkovic-Arsic et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Metabolic roles of AMPK and metformin in cancer cells
- (2013) Yeon Kyung Choi et al. MOLECULES AND CELLS
- Metformin Inhibits the Growth of Human Pancreatic Cancer Xenografts
- (2013) Krisztina Kisfalvi et al. PANCREAS
- Metformin and Survival in Pancreatic Cancer
- (2013) Allen L. Hwang et al. PANCREAS
- Different Patterns of Akt and ERK Feedback Activation in Response to Rapamycin, Active-Site mTOR Inhibitors and Metformin in Pancreatic Cancer Cells
- (2013) Heloisa P. Soares et al. PLoS One
- Metformin Targets the Metabolic Achilles Heel of Human Pancreatic Cancer Stem Cells
- (2013) Enza Lonardo et al. PLoS One
- IGF-1R as an anti-cancer target--trials and tribulations
- (2013) Helen X. Chen et al. Chinese Journal of Cancer
- Insulin-Like Growth Factor Signaling as a Therapeutic Target in Pancreatic Cancer
- (2012) Simon Rieder et al. Anti-Cancer Agents in Medicinal Chemistry
- Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study
- (2012) Saroj Niraula et al. BREAST CANCER RESEARCH AND TREATMENT
- Biomarkers in Pancreatic Cancer
- (2012) Zhi Ven Fong et al. CANCER JOURNAL
- The Pancreas Cancer Microenvironment
- (2012) C. Feig et al. CLINICAL CANCER RESEARCH
- Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer
- (2012) N. Sadeghi et al. CLINICAL CANCER RESEARCH
- Advances in Biomarker Research for Pancreatic Cancer
- (2012) Kruttika Bhat et al. CURRENT PHARMACEUTICAL DESIGN
- Metformin and the Risk of Cancer: Time-related biases in observational studies
- (2012) S. Suissa et al. DIABETES CARE
- Energy metabolism in cancer cells: How to explain the Warburg and Crabtree effects?
- (2012) Paolo Dell’ Antone MEDICAL HYPOTHESES
- KRASG12D- and BRAFV600E-Induced Transformation of Murine Pancreatic Epithelial Cells Requires MEK/ERK-Stimulated IGF1R Signaling
- (2012) V. A. Appleman et al. MOLECULAR CANCER RESEARCH
- AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress
- (2012) Sang-Min Jeon et al. NATURE
- Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
- (2012) Andrew V. Biankin et al. NATURE
- Heterodimerization of Glycosylated Insulin-Like Growth Factor-1 Receptors and Insulin Receptors in Cancer Cells Sensitive to Anti-IGF1R Antibody
- (2012) Jun Gyu Kim et al. PLoS One
- Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma
- (2012) K. M. Mann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
- (2012) Michael N. Pollak Cancer Discovery
- Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells
- (2011) B. Bao et al. Cancer Prevention Research
- Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
- (2011) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
- (2011) Joungmok Kim et al. NATURE CELL BIOLOGY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diabetes and Pancreatic Cancer
- (2011) J. Trent Magruder et al. PANCREAS
- Metformin Represses Self-Renewal of the Human Breast Carcinoma Stem Cells via Inhibition of Estrogen Receptor-Mediated OCT4 Expression
- (2011) Ji-Won Jung et al. PLoS One
- Metformin inhibits melanoma development through autophagy and apoptosis mechanisms
- (2011) T Tomic et al. Cell Death & Disease
- Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
- (2010) A. DeCensi et al. Cancer Prevention Research
- Metformin regulates breast cancer stem cello ntogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status
- (2010) Alejandro Vazquez-Martin et al. CELL CYCLE
- Crosstalk between Insulin/Insulin-like Growth Factor-1 Receptors and G Protein-Coupled Receptor Signaling Systems: A Novel Target for the Antidiabetic Drug Metformin in Pancreatic Cancer
- (2010) E. Rozengurt et al. CLINICAL CANCER RESEARCH
- Hypoxia and energetic tumour metabolism
- (2010) M Christiane Brahimi-Horn et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo
- (2010) C Algire et al. ONCOGENE
- Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: predictions of metformin interactions
- (2010) G Ahlin et al. PHARMACOGENOMICS JOURNAL
- Hypoxia Induced Tumor Metabolic Switch Contributes to Pancreatic Cancer Aggressiveness
- (2010) Sophie Vasseur et al. Cancers
- Pancreatic Cancer Biomarkers and Their Implication in Cancer Diagnosis and Epidemiology
- (2010) Mukesh Verma Cancers
- Metformin Disrupts Crosstalk between G Protein-Coupled Receptor and Insulin Receptor Signaling Systems and Inhibits Pancreatic Cancer Growth
- (2009) K. Kisfalvi et al. CANCER RESEARCH
- Antidiabetic Therapies Affect Risk of Pancreatic Cancer
- (2009) Donghui Li et al. GASTROENTEROLOGY
- The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
- (2008) I Ben Sahra et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now